drugset / Trial / NCT07546981
Efficacy and Safety of CHF 5993 100/6/12.5 μg HFA-152a pMDI in Patients With Asthma Uncontrolled on Medium Doses of Inhaled Corticosteroids in Combination With Long-acting ß2-agonists
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a study comparing CHF 5993 pMDI HFA-152a with CHF 1535 pMDI HFA-134a in Chinese patients with asthma uncontrolled on medium doses of ICS+LABA.
Timeline
- Start
- 2026-06-26
- Primary completion
- 2028-10-17
- Completion
- 2028-10-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CHF 5993 | Other / unclassified | — | Inhaled |
| Subject | CHF1535 | Unknown | — | Inhaled |